Table 3.

Factors associated with cardiac dysfunction among HIV infected children on combination antiretroviral therapy by univariate analysis

	Cardiac dysfunction		Total	Crude Odds Ratio (95% CI)	p-value
	Present (39)	Absent (246)
Age(yrs)
< 5	3	41	44	1.00
≥ 5	36	205	241	2.1 (0.635,7.40)	0.22
Gender
Female	22	132	154	1.00
Male	17	114	131	0.71 (0.35,1.46)	0.36
Viral Load (copies/ml)
<400	22	172	194	1.00
400–5000	3	12	15	1.4(0.37,5.22)	0.61
>5000	11	8	19	0.96 (0.44,2.08)	0.9
CD4 Count (cells/mm3)
<350	7	22	29	1.00
350–750	9	62	71	0.5(0.32,1.00)	0.16
>750–1000	5	36	41	0.08 (0.137,1.141)	0.19
>1000	12	88	100	0.05 (0.171,1.013)	0.11
History of TB
Yes	10	73	83	1.00
No	29	173	202	1.26(0.56,2.82)	0.56
ART
First line	28	177	205
second line	11	69	80	0.8(0.37,1.86)	0.66
Duration from HIV diagnosis
<5yrs	19	109	128
≥5yrs	20	137	157	0.89 (0.44,1.81)	0.77
Duration of ART
<5yrs	22	144	166	1.00
≥5yrs	17	102	119	0.99 (0.49,2.02)	0.99

CI – confidence interval; TB – Tuberculosis; ART – antiretroviral therapy